Association of wrist circumference with cardio-metabolic risk factors: a systematic review and meta-analysis.


Journal

Eating and weight disorders : EWD
ISSN: 1590-1262
Titre abrégé: Eat Weight Disord
Pays: Germany
ID NLM: 9707113

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 12 12 2017
accepted: 18 06 2018
pubmed: 5 7 2018
medline: 18 11 2020
entrez: 5 7 2018
Statut: ppublish

Résumé

The association of Wrist Circumference (WrC) with cardio-metabolic risk factors is still contradictory. We aimed to systematically review the association of WrC with cardio-metabolic diseases among the general populations. We systematically searched electronic databases such as PubMed/Medline, Web of Sciences, and Scopus without language restriction until March 2017. Observational studies that examined the association of WrC with any cardio-metabolic risk factors were included. Pooled association of WrC with metabolic syndrome (MetS) was estimated using a random-effect model, and heterogeneity among studies was assessed by I A total of 14 papers including cohort study (n = 9), cross-sectional study (n = 4), and case-control study (n = 1) met the criteria and included. The eligible papers have been examined the association of WrC with any cardiovascular disorders (n = 8), metabolic syndrome (n = 4), insulin resistance (IR) (n = 5), diabetes mellitus (n = 2), impaired glucose tolerance (n = 1), cardio-metabolic risk factors (n = 2) and obesity/overweight (n = 1). In the whole population (both adults and pediatric population), high WrC increased the risk of MetS by 33% (Pooled OR = 1.33; 95% CI 1.20, 1.48; I High WrC increased the risk of MetS and other cardio-metabolic risk factors. However, due to limited studies, particularly in children, results should be declared with great caution. Further cohort studies are needed to clarify whether WrC is a suitable anthropometric index to predict cardio-metabolic disorders in adult and children populations in different societies. Level 1, systematic review and meta-analysis.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
The association of Wrist Circumference (WrC) with cardio-metabolic risk factors is still contradictory. We aimed to systematically review the association of WrC with cardio-metabolic diseases among the general populations.
METHODS METHODS
We systematically searched electronic databases such as PubMed/Medline, Web of Sciences, and Scopus without language restriction until March 2017. Observational studies that examined the association of WrC with any cardio-metabolic risk factors were included. Pooled association of WrC with metabolic syndrome (MetS) was estimated using a random-effect model, and heterogeneity among studies was assessed by I
RESULTS RESULTS
A total of 14 papers including cohort study (n = 9), cross-sectional study (n = 4), and case-control study (n = 1) met the criteria and included. The eligible papers have been examined the association of WrC with any cardiovascular disorders (n = 8), metabolic syndrome (n = 4), insulin resistance (IR) (n = 5), diabetes mellitus (n = 2), impaired glucose tolerance (n = 1), cardio-metabolic risk factors (n = 2) and obesity/overweight (n = 1). In the whole population (both adults and pediatric population), high WrC increased the risk of MetS by 33% (Pooled OR = 1.33; 95% CI 1.20, 1.48; I
CONCLUSION CONCLUSIONS
High WrC increased the risk of MetS and other cardio-metabolic risk factors. However, due to limited studies, particularly in children, results should be declared with great caution. Further cohort studies are needed to clarify whether WrC is a suitable anthropometric index to predict cardio-metabolic disorders in adult and children populations in different societies.
LEVEL OF EVIDENCE METHODS
Level 1, systematic review and meta-analysis.

Identifiants

pubmed: 29971623
doi: 10.1007/s40519-018-0534-x
pii: 10.1007/s40519-018-0534-x
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-161

Subventions

Organisme : National Institute for Medical Research Development
ID : 958724

Références

Indian Pediatr. 2014 Jul;51(7):555-60
pubmed: 25031134
Anthropol Anz. 2016 Nov 1;73(4):313-321
pubmed: 27604613
J Clin Epidemiol. 2008 Jul;61(7):646-53
pubmed: 18359190
J Am Soc Hypertens. 2014 Nov;8(11):800-7
pubmed: 25455005
J Pak Med Assoc. 2012 Mar;62(3 Suppl 2):S34-6
pubmed: 22768455
BMC Med Res Methodol. 2014 Apr 01;14:45
pubmed: 24690082
Indian Heart J. 2016 Dec;68 Suppl 3:S5-S9
pubmed: 28038723
Nutr Metab Cardiovasc Dis. 2018 Jul;28(7):657-674
pubmed: 29779782
J Clin Endocrinol Metab. 2013 Feb;98(2):777-84
pubmed: 23341488
Emerg Med J. 2003 Jan;20(1):54-60
pubmed: 12533370
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
PLoS One. 2015 Apr 16;10(4):e0122985
pubmed: 25880905
Int J Obes Relat Metab Disord. 2001 Nov;25(11):1689-97
pubmed: 11753592
Am J Hum Biol. 2013 Sep-Oct;25(5):581-5
pubmed: 23897560
BMJ. 2011 Feb 10;342:d549
pubmed: 21310794
Curr Probl Cardiol. 2010 Feb;35(2):72-115
pubmed: 20109979
Nutrition. 2017 Nov - Dec;43-44:32-38
pubmed: 28935142
Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):172-8
pubmed: 17446794
Diabet Med. 2017 Feb;34(2):245-252
pubmed: 26996519
Medicine (Baltimore). 2016 Aug;95(35):e4143
pubmed: 27583845
PLoS One. 2014 Jul 16;9(7):e102563
pubmed: 25029368
Nutr Today. 2015 May;50(3):117-128
pubmed: 27340299
J Pediatr Endocrinol Metab. 2016 Sep 1;29(9):1069-76
pubmed: 27390879
J Endocrinol Invest. 2016 Jul;39(7):763-8
pubmed: 26809978
J Pediatr. 2015 Apr;166(4):1085-7
pubmed: 25596104
Circulation. 2011 Apr 26;123(16):1757-62
pubmed: 21482965
Circulation. 2008 Feb 12;117(6):754-61
pubmed: 18212291
World J Diabetes. 2014 Aug 15;5(4):444-70
pubmed: 25126392
Am J Cardiol. 2016 Sep 15;118(6):822-827
pubmed: 27457430
Obes Rev. 2008 Jul;9(4):312-25
pubmed: 17956544
Int J Obes Relat Metab Disord. 2002 Aug;26(8):1060-8
pubmed: 12119571

Auteurs

Nazli Namazi (N)

Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Shirin Djalalinia (S)

Development of Research and Technology Center, Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran.

Armita Mahdavi-Gorabi (A)

Department of Basic and Clinical Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Hamid Asayesh (H)

Department of Medical Emergencies, Qom University of Medical Sciences, Qom, Iran.

Morteza Mansourian (M)

Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.

Mehdi Noroozi (M)

Social Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Mostafa Qorbani (M)

Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. Mqorbani1379@yahoo.com.
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Mqorbani1379@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH